✦ LIBER ✦

Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial

✍ Scribed by Lau, Yu-Lung; Nelson, E. Anthony S.; Poon, Kin-Hung; Chan, Paul K.S.; Chiu, Susan; Sung, Rita; Leung, Chi Wai; Ng, Daniel; Ma, Yee Man; Chan, Desmond; Lee, Tsz Leung; Tang, Joyce; Kwan, Yat Wah; Ip, Patricia; Ho, Marco; Fung, Lai-Wah Eva; Tang, Haiwen; Suryakiran, P.V.; Han, Htay Htay; Bock, Hans

Book ID: 122048267
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 290 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.03.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and immunogenicity of two or th

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial

✍ S.A. Madhi; M. Kirsten; C. Louw; P. Bos; S. Aspinall; A. Bouckenooghe; K.M. Neuz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Immunogenicity and safety of a new menin

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial

✍ Siddhivinayak Hirve; Ashish Bavdekar; Anand Pandit; Sanjay Juvekar; Malini Patil 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Efficacy of human rotavirus vaccine agai

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial

✍ Nigel A. Cunliffe; Desiree Witte; Bagrey M. Ngwira; Stacy Todd; Nancy J. Bostock 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Safety, Immunogenicity, and Efficacy of

Safety, Immunogenicity, and Efficacy of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine in Women Aged 24–45 years: A Randomized, Double-blind Trial

✍ Corson, Stephen L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Safety and immunogenicity of a measles–m

Safety and immunogenicity of a measles–mumps–rubella–varicella vaccine given as a second dose in children up to six years of age

✍ Scott A. Halperin; Giuseppe Ferrera; David Scheifele; Gerald Predy; Giuseppe Ste 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Sustained efficacy and immunogenicity of

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB